ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/25 | 1,689 | 1,699 | 1,661 | 1,687 | -12 | -0.7% | 473,700 |
| 2023/01/24 | 1,647 | 1,730 | 1,634 | 1,699 | +91 | +5.7% | 789,800 |
| 2023/01/23 | 1,583 | 1,610 | 1,571 | 1,608 | +58 | +3.7% | 456,300 |
| 2023/01/20 | 1,544 | 1,553 | 1,526 | 1,550 | +5 | +0.3% | 247,500 |
| 2023/01/19 | 1,530 | 1,558 | 1,516 | 1,545 | -2 | -0.1% | 223,100 |
| 2023/01/18 | 1,495 | 1,550 | 1,495 | 1,547 | +64 | +4.3% | 295,300 |
| 2023/01/17 | 1,494 | 1,502 | 1,478 | 1,483 | -20 | -1.3% | 198,000 |
| 2023/01/16 | 1,488 | 1,513 | 1,487 | 1,503 | -5 | -0.3% | 188,800 |
| 2023/01/13 | 1,527 | 1,540 | 1,494 | 1,508 | -32 | -2.1% | 292,100 |
| 2023/01/12 | 1,557 | 1,587 | 1,524 | 1,540 | +5 | +0.3% | 274,000 |
| 2023/01/11 | 1,502 | 1,558 | 1,500 | 1,535 | +42 | +2.8% | 392,800 |
| 2023/01/10 | 1,550 | 1,569 | 1,486 | 1,493 | -51 | -3.3% | 382,300 |
| 2023/01/06 | 1,521 | 1,554 | 1,521 | 1,544 | +14 | +0.9% | 364,800 |
| 2023/01/05 | 1,580 | 1,582 | 1,527 | 1,530 | -54 | -3.4% | 375,200 |
| 2023/01/04 | 1,676 | 1,676 | 1,580 | 1,584 | -97 | -5.8% | 322,400 |
| 2022/12/30 | 1,691 | 1,703 | 1,680 | 1,681 | +3 | +0.2% | 175,500 |
| 2022/12/29 | 1,679 | 1,688 | 1,652 | 1,678 | +1 | +0.1% | 238,000 |
| 2022/12/28 | 1,655 | 1,688 | 1,636 | 1,677 | +9 | +0.5% | 278,700 |
| 2022/12/27 | 1,638 | 1,668 | 1,637 | 1,668 | +47 | +2.9% | 311,100 |
| 2022/12/26 | 1,659 | 1,668 | 1,616 | 1,621 | -40 | -2.4% | 271,800 |
| 2022/12/23 | 1,665 | 1,671 | 1,641 | 1,661 | -20 | -1.2% | 290,300 |
| 2022/12/22 | 1,695 | 1,698 | 1,674 | 1,681 | -8 | -0.5% | 249,300 |
| 2022/12/21 | 1,695 | 1,707 | 1,672 | 1,689 | -18 | -1.1% | 312,100 |
| 2022/12/20 | 1,776 | 1,780 | 1,693 | 1,707 | -71 | -4% | 355,700 |
| 2022/12/19 | 1,791 | 1,797 | 1,770 | 1,778 | -23 | -1.3% | 265,400 |
| 2022/12/16 | 1,805 | 1,812 | 1,787 | 1,801 | -29 | -1.6% | 385,300 |
| 2022/12/15 | 1,875 | 1,883 | 1,829 | 1,830 | -50 | -2.7% | 300,000 |
| 2022/12/14 | 1,857 | 1,904 | 1,850 | 1,880 | +39 | +2.1% | 406,000 |
| 2022/12/13 | 1,885 | 1,898 | 1,834 | 1,841 | -44 | -2.3% | 396,600 |
| 2022/12/12 | 1,878 | 1,915 | 1,868 | 1,885 | +7 | +0.4% | 232,700 |
| 2022/12/09 | 1,864 | 1,888 | 1,864 | 1,878 | +3 | +0.2% | 372,300 |
| 2022/12/08 | 1,892 | 1,896 | 1,844 | 1,875 | -14 | -0.7% | 243,800 |
| 2022/12/07 | 1,864 | 1,900 | 1,858 | 1,889 | +4 | +0.2% | 224,900 |
| 2022/12/06 | 1,880 | 1,905 | 1,880 | 1,885 | -4 | -0.2% | 238,300 |
| 2022/12/05 | 1,885 | 1,889 | 1,857 | 1,889 | +19 | +1% | 233,300 |
| 2022/12/02 | 1,900 | 1,900 | 1,866 | 1,870 | -49 | -2.6% | 332,900 |
| 2022/12/01 | 1,959 | 1,959 | 1,904 | 1,919 | +7 | +0.4% | 232,100 |
| 2022/11/30 | 1,890 | 1,919 | 1,875 | 1,912 | -8 | -0.4% | 301,000 |
| 2022/11/29 | 1,941 | 1,941 | 1,905 | 1,920 | -36 | -1.8% | 225,300 |
| 2022/11/28 | 2,000 | 2,000 | 1,938 | 1,956 | -31 | -1.6% | 261,300 |
| 2022/11/25 | 1,988 | 2,008 | 1,971 | 1,987 | +5 | +0.3% | 321,200 |
| 2022/11/24 | 1,978 | 1,991 | 1,968 | 1,982 | +22 | +1.1% | 395,700 |
| 2022/11/22 | 1,951 | 1,993 | 1,950 | 1,960 | +5 | +0.3% | 322,000 |
| 2022/11/21 | 1,957 | 1,967 | 1,947 | 1,955 | -2 | -0.1% | 270,200 |
| 2022/11/18 | 1,959 | 1,981 | 1,952 | 1,957 | -1 | -0.1% | 230,500 |
| 2022/11/17 | 1,955 | 1,990 | 1,951 | 1,958 | +4 | +0.2% | 157,200 |
| 2022/11/16 | 1,983 | 1,983 | 1,937 | 1,954 | -31 | -1.6% | 218,400 |
| 2022/11/15 | 2,000 | 2,008 | 1,958 | 1,985 | -8 | -0.4% | 439,800 |
| 2022/11/14 | 1,907 | 2,009 | 1,899 | 1,993 | +97 | +5.1% | 607,600 |
| 2022/11/11 | 1,899 | 1,917 | 1,870 | 1,896 | +41 | +2.2% | 481,700 |
451～
500
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
